PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9299374-7	1997	Stat1 and Stat3 were tyrosine phosphorylated five-fold and three-fold, respectively, over control levels following angiotensin II treatment of cardiac myocytes.	Tyrosine	21-29	signal transducer and activator of transcription 1	Rattus norvegicus	0-5	
9299374-7	1997	Stat1 and Stat3 were tyrosine phosphorylated five-fold and three-fold, respectively, over control levels following angiotensin II treatment of cardiac myocytes.	Tyrosine	21-29	signal transducer and activator of transcription 3	Rattus norvegicus	10-15	
9299374-7	1997	Stat1 and Stat3 were tyrosine phosphorylated five-fold and three-fold, respectively, over control levels following angiotensin II treatment of cardiac myocytes.	Tyrosine	21-29	angiotensinogen	Rattus norvegicus	115-129	
9299374-9	1997	Jak2 was also tyrosine phosphorylated eight-fold by angiotensin II treatment, and phosphorylated Stat1 and Stat3 proteins co-immunoprecipitated with activated Jak2 kinase.	Tyrosine	14-22	Janus kinase 2	Rattus norvegicus	0-4	
9299374-9	1997	Jak2 was also tyrosine phosphorylated eight-fold by angiotensin II treatment, and phosphorylated Stat1 and Stat3 proteins co-immunoprecipitated with activated Jak2 kinase.	Tyrosine	14-22	angiotensinogen	Rattus norvegicus	52-66	
9299374-10	1997	Selective inhibition of Jak2 kinase with AG-490 blocked formation of angiotensin II induced SIF complexes, suggesting that Jak2 kinase is required for cardiomyocyte SIF induction.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	41-47	Janus kinase 2	Rattus norvegicus	24-28	
9299374-10	1997	Selective inhibition of Jak2 kinase with AG-490 blocked formation of angiotensin II induced SIF complexes, suggesting that Jak2 kinase is required for cardiomyocyte SIF induction.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	41-47	angiotensinogen	Rattus norvegicus	69-83